Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
基本信息
- 批准号:7707072
- 负责人:
- 金额:$ 21.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-05 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllergensAllergicAsthmaBindingBiologicalBiologyCatalogingCatalogsCell ProliferationCell physiologyCellsCharacteristicsChemotaxisClinicalCommunicable DiseasesDataDevelopmentDiseaseEquilibriumExposure toExtrinsic asthmaFutureGastrointestinal tract structureGene ExpressionGenesGeneticGoalsHealthHumanHuman VolunteersImmuneImmune responseImmunosuppressionIndividualInfectionInflammationInflammatoryInflammatory ResponseInterleukin-13Interleukin-4Interleukin-5IntestinesIrrigationKnowledgeLeukocytesLocationLungMediatingModelingMolecular TargetMusNatural Killer CellsPathogenesisPhenotypePlayPopulationProcessProductionProstaglandin D2ProstaglandinsPublic HealthRecruitment ActivityRegulationReportingRoleSignal TransductionSiteSurfaceTestingTh2 CellsTimeType - attributeWorkbasecell typechemokinecytokinecytotoxicityfMet-Leu-Phe receptorhuman subjectimprovedin vivomacrophagemast cellmicrobialmouse modelmucosal sitenovelpathogenprostaglandin D receptorpublic health relevancereceptorrespiratoryresponse
项目摘要
DESCRIPTION (provided by applicant): Allergic immune responses are biased toward the production of type-2 cytokines. We have identified new surface markers of a small subset of human natural killer (NK) cells that produce the type-2 cytokines, IL-4 and IL-13. In addition, we have shown that these type-2 NK cells are enriched in the lungs of atopic human subjects in response to allergenic challenge. Therefore, our data suggest that these cells may contribute to the inflammatory response at sites of allergenic insult, such as mucosal surfaces of the lung and gastrointestinal tract. Our discovery of better surface markers to delineate these cells allows us to better purify them and define their functions. In this application, we propose exploratory studies to significantly improve our understanding of the biology of type-2 NK cells. Specifically, we will 1) catalog receptors on the human type-2 NK cells and test their impacts on biological responses, and 2) use our knowledge in humans to characterize the type-2 NK cells in mice and test whether they can also respond to allergenic challenge in a mouse model of asthma. The findings will fill significant gaps in our understanding of environmental signals that regulate the functions of type-2 NK cells, and establish a mouse model for studying their in vivo functions. Improved understanding of these biological parameters will allow us to establish the roles of type-2 NK cells in the pathogenesis of localized allergic responses and infections, particularly in the respiratory and intestinal tracts. Future studies, based upon our findings, will be able to identify molecular targets to manipulate the functions of type-2 NK cells to improve human health. PUBLIC HEALTH RELEVANCE: to Public Health Natural killer (NK) cells are normal white blood cells that can stimulate innate immune responses. We have recently discovered surface markers to define a small subset of NK cells that can enter the lungs of human volunteers after exposure to an allergen. These cells are unique, since they can produce soluble factors that may contribute to allergic inflammation, and therefore, we will further study these cells in humans and mice to establishing their role in human health and disease.
描述(由申请人提供):过敏免疫反应偏向于2型细胞因子的产生。我们已经确定了产生2型细胞因子IL-4和IL-13的一小部分人天然杀伤(NK)细胞的新表面标记。此外,我们已经表明,这些类型2 NK细胞富含特应性人体受试者的肺,以应对过敏性挑战。因此,我们的数据表明,这些细胞可能会导致过敏反应部位的炎症反应,例如肺部和胃肠道的粘膜表面。我们发现更好的表面标记来描绘这些细胞,使我们能够更好地净化它们并定义它们的功能。在此应用中,我们提出了探索性研究,以显着提高我们对2型NK细胞生物学的理解。具体而言,我们将1)人类类型-2 NK细胞上的分类受体并测试其对生物学反应的影响,2)使用人类的知识来表征小鼠中的2型NK细胞,并测试它们是否也可以在哮喘小鼠模型中对过敏性挑战做出反应。这些发现将填补我们对调节2型NK细胞功能的环境信号的理解,并建立小鼠模型来研究其体内功能。对这些生物学参数的了解的提高将使我们能够确定2型NK细胞在局部过敏反应和感染的发病机理中的作用,尤其是在呼吸道和肠道中。根据我们的发现,未来的研究将能够识别分子靶标,以操纵2型NK细胞的功能以改善人类健康。公共卫生相关性:对于公共卫生自然杀手(NK)细胞是正常的白细胞,可以刺激先天免疫反应。我们最近发现了表面标记,以定义一小部分NK细胞,这些NK细胞可以在暴露于过敏原后进入人类志愿者的肺部。这些细胞是独一无二的,因为它们可以产生可能导致过敏性炎症的可溶因子,因此,我们将进一步研究人类和小鼠中的这些细胞以确立它们在人类健康和疾病中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kerry S Campbell其他文献
Kerry S Campbell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kerry S Campbell', 18)}}的其他基金
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
- 批准号:
10319570 - 财政年份:2020
- 资助金额:
$ 21.7万 - 项目类别:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
- 批准号:
10544158 - 财政年份:2020
- 资助金额:
$ 21.7万 - 项目类别:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
- 批准号:
10078249 - 财政年份:2020
- 资助金额:
$ 21.7万 - 项目类别:
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
了解惰性淋巴细胞增殖性疾病的心理社会和免疫反应
- 批准号:
9038558 - 财政年份:2016
- 资助金额:
$ 21.7万 - 项目类别:
Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
- 批准号:
8073248 - 财政年份:2010
- 资助金额:
$ 21.7万 - 项目类别:
Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
- 批准号:
7860305 - 财政年份:2009
- 资助金额:
$ 21.7万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
7332209 - 财政年份:2004
- 资助金额:
$ 21.7万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
6860141 - 财政年份:2004
- 资助金额:
$ 21.7万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
7168804 - 财政年份:2004
- 资助金额:
$ 21.7万 - 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
- 批准号:
7013613 - 财政年份:2004
- 资助金额:
$ 21.7万 - 项目类别:
相似国自然基金
花生主要过敏原 Ara h 3 致敏的结构生物学基础
- 批准号:32372441
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
鱼类过敏原小清蛋白广谱性模拟抗原的精准构筑及构效关系研究
- 批准号:32372439
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
过敏原特异性Th2记忆前体细胞鉴定及其形成机制研究
- 批准号:82371740
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
白色念珠菌过敏原通过CGRP-IL-21-PIEZO1轴促进T细胞-小胶质细胞-神经元通讯介导瘙痒
- 批准号:82371797
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
过敏原RNA疫苗促进过敏性鼻炎中嗜酸性粒细胞分泌保护素D1诱导Treg产生机制
- 批准号:82371122
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
ECHO Renewal for the INSPIRE Study Cohort
INSPIRE 研究队列的 ECHO 更新
- 批准号:
10745075 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:
10677304 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Neuronally-driven accumulation of glycolytic MafB+MHCIIhi IMs drive airway allergy
神经元驱动的糖酵解 MafB MHCIIhi IM 积累导致气道过敏
- 批准号:
10736048 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Developing RNA Vaccines to Treat Peanut Hypersensitivity
开发治疗花生过敏的 RNA 疫苗
- 批准号:
10570339 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别: